Pursuant to Section 13 or 15(d) of the  

Securities Exchange Act of 1934




Date of Report (Date of earliest event reported): February 22, 2019


NanoVibronix, Inc.


(Exact name of registrant as specified in its charter)


Delaware   001-36445   01-0801232
(State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)


525 Executive Blvd    
Elmsford, New York   10523
(Address of principal executive offices)   (Zip Code)


Registrant’s telephone number, including area code: (914) 233-3004 


(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company ☒


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





Item 1.01 Entry into a Material Definitive Agreement.


On February 21, 2019, NanoVibronix, Inc. (the “Company”) entered into a consulting agreement (the “Agreement”) with Bespoke Growth Partners, Inc. (“Bespoke”), pursuant to which Bespoke will provide the Company with consulting services with respect to, among other things, advancement of the Company’s business plan, possible joint ventures, strategic alliances, mergers and acquisitions and related development activities (the “Services”).


In consideration for the Services, the Company paid Bespoke a cash fee of $50,000 and issued to Bespoke 275,000 shares of the Company’s common stock (“Common Stock”) upon signing the Agreement. In addition, if the Company has not previously terminated the Agreement, the Company has agreed to issue Bespoke (i) an additional 75,000 shares of Common Stock on the three (3) month anniversary of the Agreement, (ii) an additional 200,000 shares of Common Stock on the seven (7) month anniversary of the Agreement, and (iii) an additional 100,000 shares of Common Stock on the ten (10) month anniversary of the Agreement. The Agreement contains a blocker provision that prohibits the issuance of Common Stock to Bespoke during the term of the Agreement which would cause the beneficial ownership of Bespoke and its affiliates to exceed 9.99% of the Company’s outstanding shares of Common Stock.


The Agreement has an initial term of one (1) year, unless earlier terminated by the Company. The Company may terminate the Agreement before the end of the initial term upon 30 calendar days’ notice to Bespoke. The Agreement provides for indemnification of Bespoke, its officers, directors, members, employees, affiliates, and agents by the Company of all losses, expenses, damages and costs, including reasonable attorneys’ fees, resulting from any act, action or omission, except for acts of Bespoke of willful misconduct, bad faith or gross negligence related to the Agreement.


Item 3.02 Unregistered Sales of Equity Securities.


The information set forth under Item 1.01 with respect to the issuance of 275,000 shares of Common Stock to Bespoke pursuant to the Agreement is incorporated herein by reference. Such issuance was undertaken in reliance upon the exemption from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof and Rule 506 of Regulation D promulgated thereunder.







Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


  NanoVibronix, Inc.
Date: February 22, 2019 By: /s/ Stephen Brown  
    Name: Stephen Brown
    Title: Chief Financial Officer